ANT1 gene therapy for the treatment of mitochondrial disease

Active Project Grant Awarded Last action

Award ID
W81XWH2210560
Recipient
Awarding agency
Obligated
$3,520,000

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 86% complete
Originally
Funding
  • $1,760,000.00 Federal
  • $1,760,000.00 Non-federal
Place of performance
Philadelphia, PA 19104, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment ANTI1 gene therapy for the treatment of mitochondrial disease 1. Extends the POP by 12 months. Technical and financial reporting shall continue in accordance… $0 $0
Original award $1,760,000 $1,760,000

Quick answers

Who received award W81XWH2210560?

W81XWH2210560 was awarded to The Children's Hospital Of Philadelphia by Defense Health Agency (Department of Defense) on July 1, 2022.

How much is award W81XWH2210560 worth?

$3,520,000 has been obligated on W81XWH2210560: $1,760,000 in federal funding and $1,760,000 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award